RETATRUTIDE 10mg

Retatrutide is a GLP-R, GIP, and glucagon receptor tri-agonist currently being researched for its potential role in metabolic regulation and energy balance. Unlike standard GLPs receptor agonists, Retatrutide also activates the glucagon receptor, which may contribute to enhanced fat metabolism and energy expenditure.

By stimulating GLP and GIP receptors, Retatrutide has been studied for its effects on delayed gastric emptying, appetite regulation, and insulin sensitivity. Additionally, its unique activation of the glucagon receptor may support the breakdown of stored fats and glycogen, potentially increasing basal metabolism and promoting a more sustained metabolic response.

This multi-receptor approach distinguishes Retatrutide from traditional GLP agonists, offering a comprehensive pathway for metabolic and obesity research. Further studies are needed to fully understand its mechanisms and potential applications.

For research purposes only.